#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Microvillous inclusion disease Cervix carcinoma Leukocyte adhesion deficiency type I Renal disorder Cerebral amyloid angiopathy Mantle cell lymphoma recurrent Rectal cancer Cognitive disorder Fontan procedure Ocular lymphoma Heavy menstrual bleeding Alveolar proteinosis Extranodal marginal zone B-cell lymphoma (MALT type) Splenic marginal zone lymphoma Muscular dystrophy More trials…

    Learn about Rare Diseases

    Turner’s syndrome Marginal zone lymphoma – Life with Disease Behcet’s syndrome Primary hyperoxaluria – Trials in Disease Rhabdomyosarcoma recurrent – Trials in Disease Crigler-Najjar syndrome – Diagnostics Mantle cell lymphoma refractory Idiopathic pulmonary fibrosis – Diagnostics Leiomyosarcoma metastatic – Trials in Disease Skin angiosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nusinersen Fosphenytoin Sodium Retinol Palmitate Imipramine Hydrochloride Amoxicillin Pilocarpine Hydrochloride Ranitidine Hydrochloride Soticlestat Ion440 Gadoteridol Itraconazole Resmetirom Venlafaxine Hydrochloride Aavanc80-5'Hotof Sulfur Hexafluoride Povetacicept Verapamil Hydrochloride Prasinezumab Sodium Acetate (1-13C) Petrelintide More therapies…

    Learn about Your Condition

    Skin neoplasm excision Fibrosarcoma Cervical dysplasia Hypocalcaemia Red blood cell abnormality Neuropathy peripheral Behcet's syndrome Gastrectomy Infertility female Cervix carcinoma stage IV Vertebrobasilar stroke Pancreaticoduodenectomy Huntington's disease Prostate cancer recurrent Tumour thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on the Effects of Alglucosidase Alfa Enzyme Therapy in Children and Adults with Pompe Disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Alglucosidase Alfa
    The Netherlands

  • Study on the Effects of Apixaban Absorption in Patients Undergoing Roux-en-Y Gastric Bypass Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Charcoal, Activated
    • Andexanet Alfa
    • Apixaban
    The Netherlands

  • Study on the Effects of Semaglutide on Liver Fat in Obese Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Czechia

  • Study of High-Dose Hydroxocobalamin for Patients with Cobalamin Deficiency

    Not yet recruiting

    4 1 1 1
    Investigated Drugs:
    • COBALAMIN
    Spain

  • A study of orismilast alone or combined with semaglutide for weight management in people with obesity

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Orismilast
    • Semaglutide
    Denmark

  • Study on the Effectiveness of Biotin and Biotin Sodium for Children with Metabolic Disorders

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Biotinidase deficiency
    Investigated Drugs:
    • Biotin
    Spain
Previous Page
1 … 27 28 29 30 31 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!